Can Warner Chilcott Run Up The Scores On Generics?
This article was originally published in The Pink Sheet Daily
Executive Summary
Success of petition seeking to block single-scored generics of Doryx will likely rest on the brand firm's ability to make a safety and efficacy case for its dual-scored version of the antibiotic, which may be difficult given that it was marketed as a single-scored tablet for so long.